Publications by authors named "S Viswanathan"

Claim this Profile
E
Expert consensus on the clinical use of cladribine tablets for treating relapsing multiple sclerosis in the asia-pacific region.
Ho Jin Kim, Suzanne J Hodgkinson, Long-Sun Ro, Rocksy Fransisca V Situmeang, Sasitorn Siritho, Shanthi Viswanathan

Mult Scler Relat Disord· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BCL-X Dependence is a Subtype Agnostic Actionable Feature of Difficult-to-Treat Kidney Cancers.
Tupa Basuroy, Treg Grubb, Ananthan Sadagopan, Xingping Qin, Kylee Madison, Srinivas R Viswanathan

bioRxiv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the use of off-label rituximab for the treatment of multiple sclerosis in low-resource settings.
Nick Rijke, Bassem I Yamout, Deanna Saylor, Francesco Nonino, Graziella Filippini, Shanthi Viswanathan

Mult Scler Relat Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffusion-Controlled Release of Bromelain from κ-Carrageenan Nanocomposite Hydrogels Reinforced with Bio-Derived Nanofillers.
Marisa Faria, Deepa Bhanumathyamma, Gladys Maria Reji, Aswin Sreenivas Baluseri Kuttiyatt, Ghanashyam Sivaprasad, Shanthi Prabha Viswanathan

Int J Mol Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fate and function of exogenously administered mesenchymal stromal cells: current insights and future directions.
Ali Shokoohmand, Nikita M Patel, Lorena Braid, Massimo Dominici, Tracy S P Heng, Sowmya Viswanathan

Cytotherapy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis